featured
2015 Top Stories in Primary Care: “I See Less Dead People”
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- McMurray JJV, Packer M, Desai AS, et al. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. N Engl J Med. 2014; 371(11):993-1004.
- Zinman B, Wanner C, Lachin JM, et al for the EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 2015; 373(22):2117-2128.
- The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373(22):2103-2116.
- The Action to Control Cardiovascular Risk in Diabetes Study Group, Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 2008; 358(24):2545-2559.
Disclosure statements are available on the authors' profiles: